Home Other Building Blocks 78214-33-2
78214-33-2,MFCD00800712
Catalog No.:AA00390I

78214-33-2 | Ginsenoside Rh2

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$70.00   $49.00
- +
5mg
98% by HPLC
in stock  
$95.00   $67.00
- +
10mg
98% by HPLC
in stock  
$116.00   $81.00
- +
25mg
98% by HPLC
in stock  
$174.00   $122.00
- +
50mg
98% by HPLC
in stock  
$250.00   $175.00
- +
100mg
98% by HPLC
in stock  
$386.00   $270.00
- +
500mg
98% by HPLC
in stock  
$1,103.00   $772.00
- +
1000mg
98% by HPLC
in stock  
$1,726.00   $1,208.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00390I
Chemical Name:
Ginsenoside Rh2
CAS Number:
78214-33-2
Molecular Formula:
C36H62O8
Molecular Weight:
622.8727
MDL Number:
MFCD00800712
SMILES:
OCC1OC(OC2CCC3(C(C2(C)C)CCC2(C3CC(O)C3C2(C)CCC3C(CCC=C(C)C)(O)C)C)C)C(C(C1O)O)O
Properties
Computed Properties
 
Complexity:
1070  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
15  
Heavy Atom Count:
44  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
6  
Rotatable Bond Count:
7  
XLogP3:
5.6  

Literature

Title: Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype.

Journal: Chemico-biological interactions 20180301

Title: Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.

Journal: Chemico-biological interactions 20151205

Title: Sulfated derivative of 20(S)-ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-induced RAW264.7 macrophages.

Journal: Inflammation 20121001

Title: Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20121001

Title: In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20121001

Title: Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.

Journal: Bone 20120601

Title: Microbial transformation of ginsenoside Rg3 to ginsenoside Rh2 by Esteya vermicola CNU 120806.

Journal: World journal of microbiology & biotechnology 20120401

Title: Structural modification of ginsenoside Rh(2) by fatty acid esterification and its detoxification property in antitumor.

Journal: Bioorganic & medicinal chemistry letters 20120115

Title: A dynamic study on reversal of multidrug resistance by ginsenoside Rh₂ in adriamycin-resistant human breast cancer MCF-7 cells.

Journal: Talanta 20120115

Title: Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells.

Journal: British journal of pharmacology 20120101

Title: Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20120101

Title: Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.

Journal: PloS one 20120101

Title: Ginsenoside Rh2(S) induces differentiation and mineralization of MC3T3-E1 cells through activation of the PKD/AMPK signaling pathways.

Journal: International journal of molecular medicine 20111101

Title: Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.

Journal: Molecular carcinogenesis 20111001

Title: Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20111001

Title: [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20110601

Title: Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128.

Journal: Acta pharmacologica Sinica 20110301

Title: Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.

Journal: Cancer letters 20110227

Title: Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models.

Journal: Journal of cellular biochemistry 20110101

Title: 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201

Title: Cholesterol-dependent induction of dendrite formation by ginsenoside Rh2 in cultured melanoma cells.

Journal: International journal of molecular medicine 20101201

Title: Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.

Journal: Fitoterapia 20101001

Title: Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.

Journal: The Prostate 20100915

Title: Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20100901

Title: Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt.

Journal: British journal of pharmacology 20100701

Title: [Effect of ginsenoside Rh2 on the development of transferred tumors and chemotherapy efficiency].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20100401

Title: Improving enzymatic production of ginsenoside Rh2 from Rg3 by using nonionic surfactant.

Journal: Applied biochemistry and biotechnology 20100201

Title: [Research on the mechanism of ginsenoside Rh2 reversing the resistance of lung adenocarcinoma cells to cisplatin].

Journal: Zhonghua yi xue za zhi 20100126

Title: Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.

Journal: Cancer chemotherapy and pharmacology 20091101

Title: Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases.

Journal: Pharmaceutical research 20091001

Title: Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice.

Journal: Biological & pharmaceutical bulletin 20091001

Title: Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20090901

Title: Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption.

Journal: Biochemical and biophysical research communications 20090724

Title: 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity.

Journal: Bioorganic & medicinal chemistry letters 20090615

Title: Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model.

Journal: Planta medica 20090601

Title: Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20090401

Title: [Effect of ginsenoside Rh2 on transplanted-tumor and expression of JAM in mice].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20080901

Title: 20(S)-protopanaxadiol and the ginsenoside Rh2 inhibit Na+ channel-activated depolarization and Na+ channel-dependent amino acid neurotransmitter release in synaptic fractions isolated from mammalian brain.

Journal: Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080401

Title: Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.

Journal: Neuroscience letters 20080321

Title: 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.

Journal: British journal of cancer 20080226

Title: Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte.

Journal: Biochemical and biophysical research communications 20071228

Title: Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.

Journal: Biochemical pharmacology 20071203

Title: Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells.

Journal: Canadian journal of physiology and pharmacology 20071101

Title: Determination of 25-OH-PPD in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071015

Title: [Effect of ginsenoside Rh2 on immunocompetence of alveolar macrophages in patients with non-small cell lung cancer].

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20071001

Title: Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng.

Journal: Journal of microbiology and biotechnology 20070701

Title: Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells.

Journal: Neuroscience letters 20070621

Title: Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20070501

Title: Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species- and Ca2+-mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells.

Journal: The Journal of pharmacology and experimental therapeutics 20061201

Title: Quantitative determination of ginsenoside Rh2 in rat biosamples by liquid chromatography electrospray ionization mass spectrometry.

Journal: Analytical and bioanalytical chemistry 20061201

Title: Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models.

Journal: Biological & pharmaceutical bulletin 20060901

Title: [Determination of ginsenoside Rd and its metabolites in rat urine by LC-MS].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20060801

Title: Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.

Journal: Planta medica 20060601

Title: Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.

Journal: The Journal of urology 20060501

Title: In vitro assessment of plasma protein binding of 20(R)-ginsenoside Rh2 by equilibrium dialysis and LC-MS analysis: a case of species differences.

Journal: Biological & pharmaceutical bulletin 20060501

Title: 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons.

Journal: European journal of pharmacology 20060424

Title: Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide.

Journal: Basic & clinical pharmacology & toxicology 20060401

Title: [Determination of 20 (S)-ginsengnoside Rh2 in the alkali-hydrolysis product of saponins from leaves of Panax qinquefolium by RP-HPLC].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20060301

Title: Natural products from ginseng inhibit [3H]batrachotoxinin A 20-alpha-benzoate binding to Na+ channels in mammalian brain.

Journal: European journal of pharmacology 20060113

Title: Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats.

Journal: Clinical and experimental pharmacology & physiology 20060101

Title: Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats.

Journal: Planta medica 20060101

Title: Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells.

Journal: Cancer letters 20051218

Title: Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury.

Journal: Biological & pharmaceutical bulletin 20051001

Title: [Effects of ginsenoside Rh2(GS-Rh2) on cell cycle of Eca-109 esophageal carcinoma cell line].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20051001

Title: High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050425

Title: Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells.

Journal: Biological & pharmaceutical bulletin 20050201

Title: Liquid chromatography/tandem mass spectrometry for pharmacokinetic studies of 20(R)-ginsenoside Rg3 in dog.

Journal: Rapid communications in mass spectrometry : RCM 20050101

Title: Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs.

Journal: European journal of drug metabolism and pharmacokinetics 20050101

Title: Liquid chromatography/mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2.

Journal: Rapid communications in mass spectrometry : RCM 20050101

Title: [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].

Journal: Ai zheng = Aizheng = Chinese journal of cancer 20041201

Title: [Effects of ginsenoside Rh2 on signal transduction in hepatocarcinoma SMMC-7721 cells].

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20040901

Title: [Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721].

Journal: Ai zheng = Aizheng = Chinese journal of cancer 20040801

Title: Ginsenoside Rh2 induces apoptosis via activation of caspase-1 and -3 and up-regulation of Bax in human neuroblastoma.

Journal: Archives of pharmacal research 20040801

Title: Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.

Journal: Canadian journal of physiology and pharmacology 20040701

Title: Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells.

Journal: Archives of pharmacal research 20040401

Title: Ginsenoside Rh2 reduces ischemic brain injury in rats.

Journal: Biological & pharmaceutical bulletin 20040301

Title: Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.

Journal: Canadian journal of physiology and pharmacology 20040301

Title: Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.

Journal: Archives of pharmacal research 20040101

Title: Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.

Journal: Journal of biochemical and molecular toxicology 20040101

Title: The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis.

Journal: The Journal of biological chemistry 20031212

Title: In vitro induction of differentiation by ginsenoside Rh2 in SMMC-7721 hepatocarcinoma cell line.

Journal: Pharmacology & toxicology 20031201

Title: Antiallergic activity of ginsenoside Rh2.

Journal: Biological & pharmaceutical bulletin 20031101

Title: SEK1-dependent JNK1 activation prolongs cell survival during G-Rh2-induced apoptosis.

Journal: Biochemical and biophysical research communications 20030502

Title: Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells.

Journal: Acta pharmacologica Sinica 20020401

Title: [Saponins with low sugar chain from the leaves of Panax notoginseng (Burk) F. H. Chen].

Journal: Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20020301

Title: Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).

Journal: Japanese journal of cancer research : Gann 20011101

Title: The antimetastatic and immunomodulating activities of ginseng minor glycosides.

Journal: Doklady. Biochemistry and biophysics 20010101

Title: Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway.

Journal: Life sciences 19990101

Title: Guo XX, et al. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell. 2014 Mar;5(3):224-34.

Title: Wang M, et al. Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model. Oncol Lett. 2017 Feb;13(2):681-685.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:78214-33-2 Molecular Formula|78214-33-2 MDL|78214-33-2 SMILES|78214-33-2 Ginsenoside Rh2